Low and high serum IgG associates with respiratory infections in a young and working age population

We investigated health consequences and genetic properties associated with serum IgG concentration in a young and working age general population. Northern Finland Birth Cohort 1966 (NFBC1966, n = 12,231) health data have been collected from birth to 52 years of age. Relationships between life-long h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EBioMedicine 2023-08, Vol.94, p.104712-104712, Article 104712
Hauptverfasser: Holma, Pia, Pesonen, Paula, Karjalainen, Minna K., Järvelin, Marjo-Riitta, Väyrynen, Sara, Sliz, Eeva, Heikkilä, Anni, Seppänen, Mikko R.J., Kettunen, Johannes, Auvinen, Juha, Hautala, Timo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We investigated health consequences and genetic properties associated with serum IgG concentration in a young and working age general population. Northern Finland Birth Cohort 1966 (NFBC1966, n = 12,231) health data have been collected from birth to 52 years of age. Relationships between life-long health events, medications, chronic conditions, lifestyle, and serum IgG concentration measured at age 46 years (n = 5430) were analysed. Regulatory mechanisms of serum IgG concentration were considered. Smoking and genetic variation (FCGR2B and TNFRSF13B) were the most important determinants of serum IgG concentration. Laboratory findings suggestive of common variable immunodeficiency (CVID) were 10-fold higher compared to previous reports (73.7 per 100,000 vs 0.6–6.9 per 100,000). Low IgG was associated with antibiotic use (relative risk 1.285, 95% CI 1.001–1.648; p = 0.049) and sinus surgery (relative risk 2.257, 95% CI 1.163–4.379; p = 0.016). High serum IgG was associated with at least one pneumonia episode (relative risk 1.737, 95% CI 1.032–2.922; p = 0.038) and with total number of pneumonia episodes (relative risk 2.167, 95% CI 1.443–3.254; p 
ISSN:2352-3964
2352-3964
DOI:10.1016/j.ebiom.2023.104712